Artrofarm 2 ml x 3 pcs
Description:
Transparent, colorless, viscous-springy gel.
Structure:
1 ml of the drug contains the active ingredient:
sodium hyaluronate – 10 mg.
Excipients: sodium chloride, sodium dihydrogen phosphate monohydrate, sodium hydrogen phosphate heptahydrate, water for injection.
Pharmacological properties:
Hyaluronic acid is a naturally occurring polysaccharide from the family of glucosaminoglycans, the main component of the synovial fluid found in the joints, as well as in the connective tissue, skin and vitreous humor of the eye. Hyaluronic acid normalizes the cellular composition and viscosity of the articular fluid, restores its lubricating and shock-absorbing properties, regulates the functions of the synovial membrane, activates the mobility of granulactives and macrophages, eliminates the effects of inflammatory processes and prevents joint dysfunction; the synovial fluid nourishes the cartilage.
Sodium hyaluronate is an important component of the extracellular matrix, which restores the physiological homeostasis and rheological properties of the synovial fluid, contributes to the normalization of its cellular composition, activating the biosynthesis of hyaluronic acid in the cells of the synovial membrane.
Genetically engineered sodium hyaluronate is a high molecular weight (2,400,000 daltons) natural hyaluronic acid derivative.
When administered parenterally, sodium hyaluronate accumulates in high concentration in the synovial fluid, where it acts therapeutically, is metabolized in the liver, excreted in the form of carbon dioxide and water, partially remains in the body and acts continuously.
Application:
Treatment of horses, dogs, cats with inflammatory-degenerative and traumatic joint lesions of non-infectious etiology (arthrosis, synovitis, arthritis, osteoarthritis, polyarthrosis, tendovaginitis, bursitis), osteochondrosis, joint dysfunction caused by claudication, acute and chronic keratitis, conjunctivitis also for corneal ulcers and wounds.
Dosage:
Administered intravenously or subcutaneously in doses:
horses – 0.1 ml of the drug per 10 kg of body weight;
dogs weighing from 5 kg – 0.5 ml of the drug per 10 kg of body weight;
dogs and cats weighing up to 5 kg – 0.1 ml of the drug per 1 kg of body weight.
The introduction of the drug is repeated after 5-7 days, if necessary, make up to 3 injections, in case of eye diseases, the drug is instilled in 1-2 drops into the conjunctiva after 6-12 hours for 3-5 days.
If necessary, the drug can be administered to horses intra-articularly at a dose of 2 ml, with a repetition of the injection after 7 days.
Contraindications:
Not installed.
Caveats:
Before the introduction of the drug for antiseptic skin treatment, do not use drugs that contain benzalkonium chloride and chlorhexidine.
There may be swelling at the injection site, which disappears after 24-48 hours.
Do not freeze the drug!
Products after treatment of productive animals are used without restrictions.
Release form:
Glass vials are closed with a rubber stopper for aluminum rolling in 2 ml in boxes of 3 pcs.
Storage:
Dry, dark place, inaccessible to children, at temperatures from 5 ° to 25 ° C.
Use the preparation for injection immediately after the bottle is punctured; for the treatment of eye diseases – store in a refrigerator for 5 days in a closed bottle.
For use in veterinary medicine!
